Whitehawk Therapeutics's total assets for Q2 2025 were $180.82M, a decrease of -22.73% from the previous quarter. WHWK total liabilities were $8.76M for the fiscal quarter, a -28.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.